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Abstract
Background: Insulin is one of  the most important anti-diabetic agents in the management of  diabetes even among type 2 
diabetic. 
Objective: There was need to assess insulin adherence, mode of  insulin delivery and burden of  insulin usage among diabetics.
Methods: A cross-sectional, prospective questionnaire, orally administered at a Diabetes Clinic of  a University Teaching Hos-
pital, SouthWest, Nigeria. Participants were consecutive patients with diabetes who were 18 years or older presently on insulin 
either alone or in combination with other anti-diabetic agents for at least 3 months. Baseline demographic and insulin treatment 
information were obtained.
Results: Two hundred and thirteen (213) participants were studied. Of  these, 21 (9.9%) had T1DM and 192 (90.1%) had T2DM, 
(means age, 58.6 ± 13.1 years, mean duration of  diabetes, 7.0 ± 6.9 years). Insulin adherence was noted in 72.8% with better 
adherence among those who self-injected insulin compared to those who were injected by health care professionals (HCPs) or 
relations. Among the respondents, 80.8% were on human insulin and pre-mixed insulin was the most commonly used form of  
insulin (52.6%). Most participants (52.6%) were taking 10-20 units per day, only 22 (10.3%) were on >40units/day. Reuse of  
insulin needle was found in 74.6% of  the participants.  Major reasons for insulin omission were non-availability of  insulin and 
patients being tired of  insulin injection.
Conclusion: The insulin adherence among diabetics in this study was high. Non-availability of  insulin, insulin injection pain and 
being tired of  continual insulin usage were some of  the reasons for non-adherent to insulin usage.
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The burden of  diabetes mellitus (DM) and its complica-
tion is increasing worldwide and more markedly in the 
sub-Saharan Africa including Nigeria. Diabetes mellitus is 
a significant contributor to global morbidity and mortali-
ty. The most recent statistics by the International Diabe-
tes Federation (IDF) estimate that in 2015 there were 415 
million people living with DM globally1. In Nigeria, the 
reported prevalence of  DM ranges from 4.4 to 11.0%2-6. 
Out of  this number, between 14.2% and 20.8% of  per-
sons with type 2 diabetes are treated with insulin therapy 
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either alone or in combination with oral or non-insulin 
anti-diabetic agents7-9. Furthermore, with recent intro-
duction of  insulin analogues into the Nigerian market 
and adoption of  treatment-specific guideline along with 
the training of  health care practitioners there would be 
a rise in the rate of  insulin use among individuals with 
diabetes. 
Insulin therapy is an integral part of  diabetes manage-
ment in both type 1 diabetes mellitus (T1DM) and type 
2 diabetes mellitus (T2DM). In T1DM, insulin therapy 
is required from the time of  diagnosis and continued to 
be required over the lifetime of  an individual. In T2DM, 
insulin therapy is used either during acute illness associat-
ed with hyperglycaemia and hyperglycaemic emergencies, 
peri-operatively, or during pregnancy and lactation. Long-
term insulin therapy in T2DM is indicated following the 
failure of  combination anti-diabetic therapy with oral or 
non-insulin injectables to maintain optimal glycaemic 
control10. Insulin therapy is usually initiated gradually, pro-
gressing from once daily insulin regimens to premixed, 
basal-plus or basal-bolus insulin regimens while the pa-
tient is maintained on certain oral anti-diabetic therapies. 
Two types of  insulin are currently in use in Nigeria i.e. 
human insulin derived by recombinant technology or in-
sulin analogues which are genetically modified human in-
sulin in which the amino acids sequence has been altered 
to change the pharmacokinetic profile.
The pattern of  anti-diabetic treatment (especially in type 
2 diabetes mellitus) tends to change markedly along with 
the duration of  diabetes including use of  Insulin in its 
treatment. Studies have reported the benefits of  insulin 
in helping to achieve glycaemic control and reduce the 
risk of  long-term diabetes complications11,12. However, 
studies have shown concerns and barriers to initiation 
and adherence to insulin therapy especially among type 2 
diabetics13. These include errors or inaccuracies associat-
ed with the injections across the lifespan of  people with 
diabetes14. The effectiveness of  insulin therapy is related 
to adequate dosing, adherence, preservation of  its poten-
cy through proper storage and good injection techniques 
among others.
The objective of  this study was to report the pattern of  
insulin use, types, prescription, storage, common regimen 
used, adherence, sites of  insulin injection and whether 
insulin use interferes with daily routines among other de-
terminants in patients with diabetes..
 
Methodology
This was a descriptive, cross-sectional prospective study 
which was carried out at the Diabetic Clinic of  the LAUT-
ECH Teaching Hospital, Ogbomoso, Oyo State. Consec-
utive patients diagnosed of  diabetes mellitus, aged at least 
18 years old,  that were on insulin for at least 3 months 
(either alone or in combination with oral or non-insulin 
injectables anti-diabetic agents) and fulfilled inclusion cri-
teria were recruited over a period of  5 months (August 
to December 2016). Diabetic patients aged less than 18 
years old, or those older than 18 years but not on any 
form of  insulin use or on insulin for less than 3 months 
or those who were acutely ill were excluded. The physi-
cians involved in the study were specially trained for the 
study.
The following variables were obtained from each of  the 
participants: age, gender, type of  diabetes, duration of  
diabetes, and current therapy for diabetes management. 
Other information obtained were types of  insulin treat-
ment, dosage of  insulin used/day, number of  daily in-
jection, site of  injection, devices used, rotation of  in-
jection areas, frequency of  needle or syringe reuse, and 
adherence. Nature of  occupation was also obtained with 
monthly income for those who earned salary. Clinical ex-
amination was carried out to determine anthropometric 
indices, level of  blood pressure and insulin injection sites. 
Burden of  injections
Interference with eating and exercise was measured as the 
mean of  two items asking, “How much does the way you 
inject insulin interfere with eating/exercising when you 
want?” (Response options: 1 = not at all, 2 = a little, 3 = a 
moderate amount, 4 = a great deal). The reliability of  this 
scale was moderate (α = 0.80). Interference with activities 
of  daily living was measured as a count of  the affirmative 
responses to the question, “Do your insulin injections 
have a negative effect on: social activities, recreational ac-
tivities, sexual activity, work/career, family care-giving?” 
(Possible range = 0–5). Another measure of  interference 
was whether the respondent plans daily activities around 
insulin injections (1 = yes, 0 = no).
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Experience with insulin injections
There were four measures—dissatisfaction with injection 
time needed, ease of  use, pain and embarrassment—each 
measured by a single item (response options: 1 = very 
satisfied, 2 = satisfied, 3 = somewhat satisfied, 4 = not at 
all satisfied).
Frequency of  intentional/forgetting to take insulin 
omission
The dependent variable in this study was the response to 
the question, “How often do you skip insulin injections 
that you know you should take?” (Response options: 1 = 
never, 2 = rarely, 3 = sometimes, 4 = often). “How often 
do you forget to take insulin injection you were meant to 
take? (Response options: 1 = never, 2 = rarely, 3 = some-
times, 4 = often).
Definition of  terms
The subjects were considered as having diabetes mellitus 
if  diagnosis had been previously made by their physician 
as diabetics and were taking anti-diabetic agents. 
Type 1 diabetes was defined by clinical criteria-onset be-
fore 30 years of  age and using insulin since diagnosis15.
Type 2 diabetes were classified as having type 2 diabetes 
mellitus using clinical criteria such as onset after 30 years 
of  age and present/prior history of  usage of  oral anti-di-
abetic agents.
Levels of  glycaemic control was determined using aver-
age of  3 most recent fasting plasma glucose (FPG) and 
good glycaemic control referred to FPG ≤ 126mg/dl 
(7.0mmol/L)
Statistical analysis
All statistical analyses were performed with the SPSS 18.0 
software package (SPSS Inc., Chicago, Illinois, USA). Nu-
merical variables are summarized as means ± standard 
deviation and categorical variables as percentage. The sig-




The study included 213 participants, of  which 114 
(53.5%) were females. The mean age of  the participants 
was 58.57 ±13.10 years, and at least half, 107 (50.2%) 
of  the participants were 60 years old and above. Of  the 
participants, 21 (9.9%) and 192 (90.1%) had T1DM and 
T2DM respectively. More than sixty percent of  the par-
ticipants, 136 (63.9%) had secondary and/or tertiary edu-
cations, and almost four-fifth, 175 (82.2%) were married. 
About sixteen percent (15.5%) of  the participants were 
unemployed, while the rest are farmers, artisans, traders 
and civil servants. The mean fasting plasma glucose of  
the participants was 210.1 ±96.1mg/dl and 111 (52.1%) 
had hypertension (Table 1). 
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*FPG= fasting plasma glucose, SD= standard deviation 
Variable N = 213 
Frequency Percentage 
Age Group (Years)       
< 40 16 7.5 
40 – 59 90 42.3 
≥ 60 107 50.2 
Mean ± SD 58.57±13.10 
Sex Male 99 46.5 
Female 114 53.5 
Religion       
Christianity 149 70.0 
Islam 63 29.5 
Traditional 1 0.5 
Education       
None 23 10.8 
Primary 60 28.2 
Secondary 71 33.3 
Tertiary 59 27.7 
Income       
< 20,000 99 46.5 
20,000 – 50,000 65 30.5 
50,000 – 100,000 36 16.9 
> 100,000 13 6.1 
Occupation       
Unemployed 33 15.5 
Farming 16 7.5 
Trading 54 25.4 
Artisan 12 5.6 
Civil Servant 37 17.4 
Professional Job 3 1.4 
Others 58 27.2 
Diabetes type       
Type 1 21 9.9 
Type 2 192 90.1 
History of Hypertension       
Yes 111 52.1 
No 102 47.9 
History of smoking       
Yes 8 3.8 
No 205 96.2 
History of Alcohol       
Yes 16 7.5 
No 197 92.5 
Good glycaemic control (FPG 
< 126mg/dl) 
      
Yes 69 32.4 
No 144 67.6 
Duration of Diabetes (years) Mean ± SD 7.04±6.94 
Median (Range) 5.00 (0.10 – 54.0) 
Duration of Insulin (years) Median (Range) 1.50 (0.10 – 40.0) 
FPG (mg/dl) Mean ± SD 210.09 ± 96.14 
Patterns of  insulin used
The number of  insulin injected per day was one in 39 
(18.3%), two in 159 (74.6%), three in 13 (6.1%) and more 
than three in 2 (0.8%). Insulin administration devices 
used were insulin syringes 118 (55.4%) and insulin pen 95 
(44.6%). Majority of  participants, 153 (71.8%) self-inject 
themselves, while spouses, relatives and health care pro-
viders assists others with insulin injection (Table 2).
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Table 2: Insulin pattern 
 
Insulin Type       
Rapid acting 28 13.1 
Soluble 47 22.1 
NPH 9 4.2 
Premixed 112 52.6 
Long-acting 13 6.1 
Soluble + NPH 3 1.4 
Soluble + NPH + Premixed 1 0.5 
Insulin Frequency       
Once 39 18.3 
Twice 159 74.6 
Thrice 13 6.1 
> 3 times 2 0.9 
Device Type       
Syringes 118 55.4 
Pen 95 44.6 
Insulin Amount       
<10 U 15 7.0 
10 – 20U 112 52.6 
21 – 40U 64 30.0 
> 40U 22 10.3 
Location Insulin is kept       
Refrigerator 179 84.0 
Beside clay water pot 3 1.4 
Inside cup of water 7 3.3 
Under the bed 4 1.9 
Others 20 9.4 
*NPH= Neutral Protamine Hagedon 
Variable N = 213 
Frequency Percentage 
   
Insulin injection technique & insulin storage
In this study, the most commonly used site for injection 
was thigh only in  75 (35.2%), then only arm 39 (18.3%) 
and least in buttock 6 (2.8%),and many participants used 
more than one site for injection (Figure 1A). However, 
significantly higher number of  participants was rotating 
the injection site with each injection. A large proportion 
(43.1%) of  patients reused the same needle for injecting 
for more than 3 times, and some (15.0%) reused needle 
for up to 10 times before discarding. 
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 Figure 1.A. Venn diagram showing the frequencies of and overlap between different sites of insulin  
 injection  in the patients. B. Representation of abdomen and buttock. C. Representation of arm and thigh. 
Insulin adherence
Adherence to insulin administration was noted in 72.8% 
of  the study participants. Short time glycaemic con-
trol i.e. FPG ≤126mg/d; (7.0mmo/L) was achieved 
in 69 (32.4%). The mean FPG was significantly higher 
(p=0.03) in those who admitted to non-insulin adherence 
compared to those who adhered to their insulin regimens. 
More than a quarter (27.2%) of  participants reported 
skipping insulin injections they should take; out of  which 
14.6% of  these reported skipping insulin sometimes or 
often. A greater proportion of  persons who self-injected 
insulin adhered to insulin prescription compared to those 
whose injections are administered by others (Table 3).
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Table 3: Insulin Injection techniques and practices 
 
Do you rotate site?       
Never 18 8.5 
Rarely 9 4.2 
Sometimes 61 28.6 
Often 125 58.7 
Do you swab site?       
Never 177 83.1 
Rarely 34 16.0 
Often 2 0.9 
Swab substance       
Water 29 13.6 
Methylated Spirit 169 79.3 
Water + Methylated Spirit 13 6.1 
Others 2 0.9 
Do you reuse your needles?       
Yes, how often? 
    1 – 3 times 







    31.5 
   18.8 
    9.4 







Variable N = 213 
Frequency Percentage 
No 54 25.4                  
Do you know how to inject?       
Yes 164 77.0 
No 49 23.0 
Do you inject yourself?       
Yes 153 71.8 
No, but who administers 
    Spouse 
    Relative 
    Health Care Workers 
60 
    30 
    19 
    11 
28.2 
    14.1 
    8.9 
    5.2 
Do you forget to take your Insulin?       
Yes, how often? 
    Rarely 
    Sometimes 
    Often 
43 
    23 
    14 
    6 
20.2 
    10.8 
    6.6 
    2.8 
No 170 79.8 
Do you sometimes refuse to take Insulin?       
Yes, how often? 
    Rarely 
    Sometimes 
    Often 
58 
    27 
    20 
    11 
27.2 
    12.7 
    9.4 
    5.2 
No 155 72.8 
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Reasons forinsulin omission
All of  the 7 major reasons for insulin omission are as 
shown in Figure 2; the commonest cause of  insulin omis-
sion which occurred in 42 (20.2%) was insulin not avail-
able. 
 
*INA= Insulin not available, IP= Insulin pain, PTANA= Person to administer not available, E= Embarrassment, IWDA= Interference with daily activities,  
TOII= Tired of insulin injection, O= Others. 
 
Figure 2: Reason for omitting insulin. 
 
*INA= Insulin not available, IP= Insulin pain, PTANA= Person to administer not available, E= Embarrassment, IWDA= Interference with daily activities,  
TOII= Tired of insulin injection, O= Others. 
 
Figure 2: Reason for omitting insulin. 
Hypoglycaemia and self-monitoring of  blood glu-
cose (SMBG)
While a total of  158 (74.2%) of  the study participants 
had glucometers, but 128 (69.4%) do self-monitoring 
of  blood glucose (SMBG). The number of  participants 
who checked their blood glucose everyday was 64 (30%) 
while 84 (39.4%) checked their blood glucose 3-10 times/
months. Almost a third (31.9%) of  participants have had 
at least an episode of  hypoglycaemia within the last 3 
months but only 17 (7.9%) had ≥3 episodes of  hypogly-
caemia in the last 3 months. Of  the 21 participants who 
had been managed in the hospital on account of  hypo-
glycaemia within the last 3 months, 20/21 (95.2%) had 
admission only 1-2 times (Table 4).
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Possess glucometers       
Yes 158 74.2 
No 55 25.8 
SMBG frequency       
Never 12 5.6 
Rarely (1 – 2) 53 24.9 
Sometimes (3 – 5) 45 21.1 
Often (6 – 10) 39 18.3 
Everyday 64 30.0 
Experience of hypoglycaemia       
Yes, how often? 
Rarely (1 – 2) 
Sometimes (3 – 5) 












No 145 68.1 
Hypoglycaemia admission       
Yes, how many times? 
 1 – 2 times 
    3 – 5 times 









No 192 90.1 
 
Insulin injection sites examinations
Figure 3 showed the distribution of  adverse skin reac-
tions noted at the insulin injection sites. The commonest 
skin lesion noted was hyperpigmentation found in 21.1% 




               Figure 3: Inspection of the insulin injection sites. 
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Insulin burden
A substantial number of  participants (40.4%) said they 
planned their daily activities around their insulin injec-
tions and (20.2%) reported that insulin injections inter-
fered with their eating/exercise. Almost one-fifth (20.2%) 
of  the participants said that insulin injections had a neg-
ative effect on their social activities. A significant propor-
tion of  participants (71.9%) reported moderate levels of  
non-satisfaction with the insulin pain. Ease of  insulin 
used noted only in (44.1%) of  the study participants (Ta-
ble 5).
Table 5: Burden of insulin injection 
 
Burden Not at all Little amount Moderate amount Great deal 
N (%) N (%) N (%) N (%) 
Interference with eating/exercise 170 (79.8) 30 (14.1) 12 (5.6) 1 (0.5) 
Negative effect on social activities 169 (79.3) 28 (13.1) 14 (6.6) 2 (0.9) 
Daily activities around injection 127 (59.6) 48 (22.5) 17 (8.0) 21 (9.9) 
  Very satisfied satisfied Somewhat satisfied Not at all satisfied 
Ease of Insulin used 94 (44.1) 82 (38.5) 27 (12.7) 10 (4.7) 
Pain 60 (28.2) 74 (34.7) 56 (26.3) 23 (10.8) 
  
  Discussion
Despite the importance of  adhering to prescribed insu-
lin regimens, little is known about the degree to which 
patients are adhering. In this study, 69.0% of  the partici-
pants practiced SMBG. The proportion of  patients who 
performed SMBG in our study was slightly lower than 
70-80% reported  by workers in developed countries16,17 
but significantly higher than 40% reported by Iwuala et 
al18 in Nigeria. Although the issue of  cost as a possible 
barrier to SMBG amongst Nigerians with DM is already 
stated, because the expenses are mostly borne out-of-
pocket19. However, diabetic patients on insulin are usually 
encouraged by their health care providers to monitor their 
blood glucose, hence the relatively high number of  dia-
betics that owned glucometers and monitored their blood 
glucose in this study. The American Diabetes Associa-
tion (ADA) has statutory recommendations for SMBG 
on use of  glucometer in all diabetic patients on insulin20. 
Approximately 30% of  our patients did not have access 
to glucometer, although they are on insulin. Other studies 
from developing countries like Kenya reported a lower 
utilization of  glucometers and adherence21,22.
Insulin syringes were used by 55.4% of  our participants, 
whereas 44.6% used insulin pen device. This finding is 
similar to the 45% of  diabetic patients on insulin pen de-
vice in the USA, but higher than 33% reported in Mex-
ico23 and 29% by Ogbera et al24 in Lagos. Our findings 
were different from that of  the DiabCare India Study 
where 65.6% used pen device, 32.0% used syringes25. 
Also findings from multinational MOSA1C revealed that 
majority used pen device over syringes in countries like 
China (100%), Germany (95%), Russia (93%) and Saudi 
Arabia (63%)23. Data from a recent large worldwide sur-
vey indicated that insulin pen alone was used by 85.6% 
of  patients, while 9.6% used a syringe device, 2.8% used 
both, and 1.4% used a pen and another device (usually 
insulin pumps)26. Insulin syringes remain the commonly 
used delivery device due to its accessibility. Insulin pens 
which are more convenient to use, more accurate, take 
less time to teach patients and its needle less painful are at 
present not as readily available as insulin syringe to most 
patients with diabetes at the study centre. Also noted in 
this study, was the relatively low use of  insulin analogues. 
In the study reported by Ogbera et al24 in 2012, the per-
centage of  insulin analogue use was 29% compared to 
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19.2% in this study. The reasons for the lower use of  in-
sulin analogue may be partly due to lower disposable in-
come among our participants. Insulin analogues are more 
expensive than human insulin and also less accessible in 
our study centre.
This study showed that only 38.5% of  the participants 
had adequate glycaemic control (FPG< 126mg/dl) and it 
is consistent with other studies27,28 who reported similar 
low glycaemia control. Glycated haemoglobin (HbA1C) 
which is considered as gold standard to assess levels of  
glycaemic control was not used among our participants; 
hence, the use of  FPG levels (average of  3 most recent 
FPG tests) was used to assess and monitor glyceamic con-
trol. The ADA position statement with the standard of  
diabetic care recommend that a patient with good glycae-
mic control, at least HbA1C test be done twice per year 
while in patients with poor glycaemic control, HbA1C 
test should be done 3-4 monthly20.
Also noted in this study is the high rate of  insulin needle 
reuse (74.6%) among our patients; 9.4% reused needle 
7-10 times and 15.0% reused insulin needle more than 10 
times. In a study by Frid et al26, they found needle reuse 
in approximately half  of  the patients worldwide, almost 
a third using the same needle up to 6 times. Also, Baruah 
et al29 found 72.2% of  their patients reused insulin nee-
dle and 98.9% in the South Indian Study30. In contrast, 
more than 80% of  patients avoid needle reuse in devel-
oped nations like Italy31. Recent guidelines have strong-
ly discouraged needle reuse although optimal cutoff  for 
maximum number of  injection reuse has not been set32. 
Major reasons thought to be responsible for the high rate 
of  needle reuse in our study are cost and inadequate ed-
ucation of  the patients by the health care providers. As 
previously reported by Olamoyegun et al14, even health 
care practitioners (HCPs) had poor knowledge of  insulin 
use, hence may not be able to give patients adequate assis-
tance, when they raise the issue with them.
In the present study, the storage condition of  insulin was 
appropriate as majority of  participants stored their insu-
lin in the refrigerator. Vials of  insulin not in use should be 
refrigerated. Excessive temperatures (<20C or 280C) and 
excessive shaking should be avoided to prevent loss of  
potency, clumping, frosting and precipitation. Insulin in 
use may be kept at room temperature, behind local water 
pot and in cool places away from direct sunlight in the 
absence of  refrigerator so as to maintain potency.
Adherence to anti-diabetic agents including insulin is one 
of  the important determinants of  optimal glycaemic con-
trol among diabetics. Insulin adherence rate in this study 
of  79.8% is comparable to 77% reported by Ogbera et 
al24 in a previous study in Nigeria. Majority of  our pa-
tients practiced self-insulin injection, hence positively af-
fected their insulin adherence. In contrast to other studies 
that found evidence of  poor adherence to insulin therapy 
among patients with diabetes33 they noted that only 28% 
of  their patients were adherent to insulin therapy.
We noted that some patients deliberately omitted or for-
got to inject the insulin they were meant to take. In this 
study, pain, ease of  insulin use and embarrassment asso-
ciated with insulin injection resulted in insulin omission. 
This is similar to findings by Peyrot et al who reported 
pain and embarrassment as some of  the reason for in-
sulin omission among both type 1 and type 2 diabetic 
patients33. Our study also suggests that insulin omission 
is affected by the perceived burden of  insulin therapy in-
cluding having to plan one’s life around insulin injections 
and feeling that the insulin regimens interfere with activ-
ities of  daily living such as social activities. Measures to 
reduce this perceived burden of  insulin injections may re-
quire repeated health education by health care providers 
emphasizing adherence. Also, a finding in this study sug-
gests that insulin omission may be affected by previous 
or perceived experience that injecting insulin is painful 
and uncomfortable. However, adopting alternative ways 
to deliver insulin like insulin pens, finer gauge needles are 
some of  the ways to reduce pain, reduce inconvenience 
and ameliorate embarrassment. Measures adopted to ad-
dress pain and embarrassment due to insulin injection 
may also help to lessen the emotional burden of  injec-
tions, thereby improving psychological well-being and 
adherence.
Limitations of  the study include the fact that measure 
of  insulin adherence was based on patients’ admittance 
rather than objective means like pharmacy records or 
frequency of  drugs refill. Also, long-term glycaemic con-
trol was assessed with average of  three most recent FPG 
rather than with glycated haemoglobin which is the usual 
measure of  long-term glycaemic control25. 
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